Medicare Market Shares: Why the Big Plans Don't Mind Losing Ground
This article was originally published in RPM Report
Executive Summary
United and Humana remain by far the biggest players in the stand-alone drug insurance market for Medicare, but the field is gaining on them. They don't seem to mind. Is that a sign that the market is "mature"? Or a warning of rocky times ahead for a critical program for pharma.
You may also be interested in...
Not So Random Selection: Medicare Agency Cuts "Churn" In Part D Enrollment
One of the Obama Administration's first moves in managing the Medicare Part D benefit is to tamp down on the number of beneficiaries who will be randomly assigned to a new plan on Jan. 1. Stability is good for the program politically, but it may also be a sign of more hands-on management by the Medicare agency in the years ahead.
Not So Random Selection: Medicare Agency Cuts "Churn" In Part D Enrollment
One of the Obama Administration's first moves in managing the Medicare Part D benefit is to tamp down on the number of beneficiaries who will be randomly assigned to a new plan on Jan. 1. Stability is good for the program politically, but it may also be a sign of more hands-on management by the Medicare agency in the years ahead.
The Threat of Reconciliation: Remembering the Part D Vote
Democrats are threatening to use a budgetary procedure to accelerate the passage of broad health reforms in the next Congress. Republicans are already voicing protest, particularly with the idea of a new government-run insurance plan gaining momentum. But those concerns may fall on deaf ears.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: